Literature DB >> 11347758

Glucose control and cardiovascular complications: the VA Diabetes Trial.

W C Duckworth1, M McCarren, C Abraira.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11347758     DOI： 10.2337/diacare.24.5.942

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  17 in total

Review 1.  Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research.

Authors:  Benjamin M Leon; Thomas M Maddox
Journal:  World J Diabetes       Date:  2015-10-10

Review 2.  Glucose targets for preventing diabetic kidney disease and its progression.

Authors:  Marinella Ruospo; Valeria M Saglimbene; Suetonia C Palmer; Salvatore De Cosmo; Antonio Pacilli; Olga Lamacchia; Mauro Cignarelli; Paola Fioretto; Mariacristina Vecchio; Jonathan C Craig; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2017-06-08

Review 3.  Repaglinide: a review of its therapeutic use in type 2 diabetes mellitus.

Authors:  C R Culy; B Jarvis
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Exercise and Cardiovascular Risk among Masters Athletes with Type 2 Diabetes.

Authors:  Erika J Parisi; Aaron L Baggish
Journal:  Curr Diab Rep       Date:  2019-11-14       Impact factor: 4.810

5.  Coronary artery and abdominal aortic calcification are associated with cardiovascular disease in type 2 diabetes.

Authors:  P D Reaven; J Sacks
Journal:  Diabetologia       Date:  2005-02-02       Impact factor: 10.122

Review 6.  Hyperglycemia and cardiovascular disease.

Authors:  W C Duckworth
Journal:  Curr Atheroscler Rep       Date:  2001-09       Impact factor: 5.113

7.  A zebrafish model of diabetes mellitus and metabolic memory.

Authors:  Robert V Intine; Ansgar S Olsen; Michael P Sarras
Journal:  J Vis Exp       Date:  2013-02-28       Impact factor: 1.355

Review 8.  Reduction of cardiovascular morbidity and mortality in type 2 diabetes. A rational approach to hypoglycemic therapy.

Authors:  P Spallarossa; A Barsotti; R Cordera; G Ghigliotti; D Maggi; C Brunelli
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

9.  Lack of effect of bezafibrate and fenofibrate on the pharmacokinetics and pharmacodynamics of repaglinide.

Authors:  Lauri I Kajosaari; Janne T Backman; Mikko Neuvonen; Jouko Laitila; Pertti J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  2004-10       Impact factor: 4.335

10.  Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis.

Authors:  Peter D Reaven; Thomas E Moritz; Dawn C Schwenke; Robert J Anderson; Michael Criqui; Robert Detrano; Nicholas Emanuele; Moti Kayshap; Jennifer Marks; Sunder Mudaliar; R Harsha Rao; Jayendra H Shah; Steven Goldman; Domenic J Reda; Madeline McCarren; Carlos Abraira; William Duckworth
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.